FIELD: medicine.
SUBSTANCE: what is presented is using 1-(β-phenylethyl)-4-amino-1,2,4-triazolium bromide as an active drug base for the purpose of correcting the nitroxydergic malfunctions.
EFFECT: higher activity of endothelial NO-synthase and high NO production under the action of the declared agent that has higher efficacy as compared to the known analogues, and has no side effects.
2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USING 1-(β-PHENYLETHYL)-4-AMINO-1,2,4-TRIAZOLIUM BROMIDE (HYPERTRIL) AS ACTIVE BASE OF DRUG PREPARATIONS FOR CORRECTING DYSFUNCTIONS OF NITROXYDERGIC SYSTEM OF TARGET ORGANS ACCOMPANYING HOMOCYSTEINEMIA AND ACUTE CEREBROVASCULAR DISORDERS | 2013 |
|
RU2532394C1 |
| METHOD FOR SIMULATING ENDOTHELIAL DYSFUNCTION AND PATHOLOGY OF INTERNAL ORGANS IN EXPERIMENT | 2019 |
|
RU2712102C1 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY RECOMBINANT ERYTHROPOIETIN IN ADMA-LIKE GESTOSIS MODEL | 2011 |
|
RU2462766C1 |
| METHOD FOR CORRECTION OF OXIDATIVE STRESS AND NO PRODUCING ENDOTHELIAL DYSFUNCTION ACCOMPANYING VASCULAR COMPLICATIONS OF DIABETES MELLITUS IN EXPERIMENT | 2013 |
|
RU2521279C1 |
| METHOD OF DETERMINING EFFECTIVENESS OF TREATMENT OF ENDOTHELIAL DYSFUNCTION IN METABOLIC AND FUNCTIONAL DISORDERS IN EXPERIMENTAL RATS | 2023 |
|
RU2808420C1 |
| COMPOSITION POSSESSING ENDOTHELIAL PROTECTIVE, VASODILATING AND ANGIOPROTECTIVE EFFECT | 2011 |
|
RU2464019C1 |
| METHOD FOR ENDOTHELIAL DYSFUNCTION CORRECTION BY DISTANT PRECONDITIONING IN ADMA-LIKE GESTOSIS MODEL | 2011 |
|
RU2462765C1 |
| METHOD FOR AZITHROMYCIN-BASED ENDOTHELIAL DYSFUNCTION CORRECTION IN EXPERIMENTAL REACTIVE VASCULITIS | 2009 |
|
RU2402333C1 |
| METHOD FOR PLACENTAL MICROCIRCULATION DISORDER CORRECTION IN ADMA-LIKE GESTOSIS MODEL | 2011 |
|
RU2460148C1 |
| USE OF OXATHRIAZOLO-5-OLATE FOR TREATING SEXUAL DISORDERS | 2014 |
|
RU2600845C2 |
